Effect of the use of dialyzer having excellent performance for removal of cytokines on clinical observation in maintenance HD patients - Tokai Cytokine Removal Study

Tokai Cytokine Removal Study Group0 个研究点目标入组 20 人开始时间: 2013年4月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Patients who are receiving renal replacement therapies other than hemodialysis, continuous ambulatory peritoneal dialysis and hemodiafiltration, excluding hemodialysis. 2) Patients who are enrolled to other clinical study. 3) Cancer bearing patients or a patient who received radical surgery for cancer in less than 3 years. 4) Patients who have a history of cardiovascular diseases (myocardial infarction, stroke) in less than 6 months. 5) Patients who have peripheral arterial disease classified in more than Fontaine classification class II. 6) Patients who have uncontrolled diabetes despite standard treatments. 7) Patients who are considered to have acute inflammation with CRP of higher than 2 mg/dL. 8) Patients with uncontrolled anemia (Hb <8.5 g/dL) despite ESA treatment. 9) Patients who are pregnant or intends to become pregnant within one year. 10) Patients who are judged as the inadequate subject of this study by the doctor.

发起方

Tokai Cytokine Removal Study Group